Company press releases
Tid | Selskap | Tittel | Sektor | Kategori |
---|---|---|---|---|
07 Jun 2022 13:00 CEST |
ACACIA PHARMA | Court Sanction of the Scheme of Arrangement | 20103010 Biotechnology | Other subject |
20 May 2022 08:00 CEST |
ACACIA PHARMA | Acacia Pharma Results of the Court Meeting and the General Meeting held on 19 May 2022 | 20103010 Biotechnology | Other subject |
29 Apr 2022 23:02 CEST |
ACACIA PHARMA | Publication of Annual Report and Financial Statements for the Year ended 31 December 2021 | 20103010 Biotechnology | Other subject |
27 Apr 2022 12:00 CEST |
ACACIA PHARMA | Publication of Scheme Document | 20103010 Biotechnology | Mergers, Acquiqitions, Transferts |
31 Mar 2022 18:00 CEST |
ACACIA PHARMA | Acacia Pharma Group plc - Total Number of Voting Rights and Capital | 20103010 Biotechnology | Other subject |
30 Mar 2022 18:00 CEST |
ACACIA PHARMA | Acacia Pharma to Postpone Publication of its Results for the Full Year 2021, Scheduled on 31 March 2022 | 20103010 Biotechnology | Other subject |
28 Mar 2022 08:00 CEST |
ACACIA PHARMA | Offer by Eagle Pharmaceuticals, Inc. | 20103010 Biotechnology | Mergers, Acquiqitions, Transferts |
23 Mar 2022 07:10 CET |
ACACIA PHARMA | Acacia Pharma Announces Chief Financial Officer Gary Gemignani is to Leave the Company | 20103010 Biotechnology | Other subject |
15 Mar 2022 18:07 CET |
ACACIA PHARMA | Issue of Shares to Employee Benefit Trust | 20103010 Biotechnology | Other subject |
21 Dec 2021 07:00 CET |
ACACIA PHARMA | Acacia Pharma Issues Ordinary Shares to its Employee Benefit Trust | 20103010 Biotechnology | Other subject |
16 Dec 2021 12:18 CET |
ACACIA PHARMA | Correction: Issue of Shares to Employee Benefit Trust | 20103010 Biotechnology | Other subject |
16 Dec 2021 07:00 CET |
ACACIA PHARMA | Issue of Shares to Employee Benefit Trust | 20103010 Biotechnology | Other subject |
13 Dec 2021 07:00 CET |
ACACIA PHARMA | Acacia Pharma Announces Successful Completion of BARHEMSYS® Post-approval Requirement Study in Patients with Severe Renal Impairment | 20103010 Biotechnology | Other subject |
30 Sep 2021 07:00 CEST |
ACACIA PHARMA | Interim Results for the Six Months ended 30 June 2021 - Barhemsys® and Byfavo® Launches Continue to Achieve Strong Hospital Formulary Adoption | 20103010 Biotechnology | Other subject |
29 Sep 2021 07:00 CEST |
ACACIA PHARMA | Acacia Pharma Announces Submission and Validation of Marketing Authorization Application for BARHEMSYS® (amisulpride injection) in Major European Markets | 20103010 Biotechnology | Other subject |
23 Sep 2021 13:10 CEST |
ACACIA PHARMA | Correction: Notice of Results | 20103010 Biotechnology | Other subject |
23 Sep 2021 13:00 CEST |
ACACIA PHARMA | Notice of Results | 20103010 Biotechnology | Other subject |
16 Sep 2021 07:00 CEST |
ACACIA PHARMA | Acacia Pharma Announces Initiation of Pivotal Study of Byfavo® in Pediatric Procedural Sedation | 20103010 Biotechnology | Other subject |
02 Sep 2021 07:00 CEST |
ACACIA PHARMA | Acacia Pharma to Host Webinar with Key Opinion Leaders to Discuss the Hospital User Experience with Barhemsys® and Byfavo® | 20103010 Biotechnology | Other subject |
05 Jul 2021 15:02 CEST |
ACACIA PHARMA | Correction: Transparency Notification - PDF of Notification attached | 20103010 Biotechnology | Other subject |
01 Jul 2021 08:00 CEST |
ACACIA PHARMA | Transparency Notification | 20103010 Biotechnology | Other subject |
01 Jul 2021 07:00 CEST |
ACACIA PHARMA | Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US | 20103010 Biotechnology | Other subject |
29 Jun 2021 07:00 CEST |
ACACIA PHARMA | Results of Annual General Meeting | 20103010 Biotechnology | General meeting / Board Meeting |
25 May 2021 18:00 CEST |
ACACIA PHARMA | Acacia Pharma Group plc: Notice of Annual General Meeting | 20103010 Biotechnology | General meeting / Board Meeting |
25 May 2021 12:00 CEST |
ACACIA PHARMA | Acacia Pharma to Participate in Jefferies Virtual Healthcare Conference | 20103010 Biotechnology | Meetings / events |
19 May 2021 07:00 CEST |
ACACIA PHARMA | Acacia Pharma Appoints Debra Hussain as Chief Commercial Officer | 20103010 Biotechnology | Other subject |
04 May 2021 07:00 CEST |
ACACIA PHARMA | Acacia Pharma Announces Early Repayment of Loan Facility from Hercules Technology Growth Capital and Reduction in Debt Service Obligations | 20103010 Biotechnology | Other subject |